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Proprotein convertase 1 (PC1) is a neuroendocrine proteinase involved in the proteolytic activation of precursors to hormones and
neuropeptides. To determine the physiological importance of PC1, we produced a mutant mouse from embryonic stem cells in which its locus
(Pcsk1) had been inactivated by homologous recombination. The inactivating mutation consisted of a 32.7-kb internal deletion and a 1.8 kb
insertion of the bacterial neomycin resistance gene (neo) under the mouse phosphoglycerate kinase 1 protein (PGKneo). Intercross of Pcsk1+/−
mice produced no Pcsk1−/− offspring or blastocysts; in addition, more than 80% of the offspring were Pcsk1+/−. These observations suggested that
the mutation caused preimplantation lethality of homozygous embryos and preferential transmission of the mutant allele. Interestingly, RT–PCR
analysis on RNA from endocrine tissues from Pcsk1+/− mice revealed the presence of aberrant transcripts specifying the N-terminal half of the
PC1 propeptide fused to neo gene product. Mass spectrometric profiles of proopiomelanocortin-derived peptides in the anterior pituitary were
similar between Pcsk1+/− and Pcsk1+/+ mice, but significantly different between male and female mice of the same genotype. Relative to their
wild-type counterparts, female mutant mice exhibited stunted growth under a low fat diet, and catch-up growth under a high-fat diet. The complex
phenotype exhibited by this Pcsk1 mutant mouse model may be due to PC1 deficiency aggravated by expression of aberrant gene products from
the mutant allele.
© 2007 Elsevier Inc. All rights reserved.Keywords: Proprotein convertase; PC1; Pcsk1; Genetic deficiency; Preimplantation embryonic lethality; Transmission ratio distortionIntroduction
PC1, also known as PC3 (Smeekens et al., 1991) or SPC3
(Steiner, 1998), belongs to a family of serine proteinases that
activate secretory precursor proteins by cleavages after selected
pairs of basic residues (Seidah and Chretien, 1999; Steiner,
1998). In mouse, its Pcsk1 locus maps to chromosome 13
(Seidah et al., 1991). The gene has 15 exons and 14 introns⁎ Corresponding author. Ottawa Health Research Institute, 725 Parkdale
Avenue, Room 117-1, Ottawa, Ontario, Canada K1Y 4E9. Fax: +1 613 761 4355.
E-mail address: mmbikay@ohri.ca (M. Mbikay).
1 These two authors have equally contributed to this work.
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doi:10.1016/j.ydbio.2007.03.523(Ftouhi et al., 1994). It is transcribed into two major mRNA
isoforms of 2.8 and 4.4 kb differing in their 3′ untranslated
regions (UTR) (Seidah et al., 1991) (Ftouhi et al., 1994). These
transcripts are primarily found in neuroendocrine cells (Schäfer
et al., 1993; Seidah et al., 1991, 1994; Zheng et al., 1994). They
are translated in the endoplasmic reticulum (ER) into a 88-kDa
proPC1; the zymogen gets converted in the ER and the Golgi to
a 74-kDa form by autocatalytic removal of the prodomain; the
mature enzyme is then sorted into secretory granules where it is
further processed to its fully active form of 66-kDa by excision
of a C-terminal fragment (Benjannet et al., 1993). The pro-
domain may promote the proper folding of proPC1 and its exit
from the ER, as demonstrated for other PCs (Anderson et al.,
Table 1
Distorted genotype distribution among offspring of heterozygote intercrosses a
Pcsk1 genotype b ♀ ♂ Total % c
+/+ 47 41 88 20
+/− 180 175 355 80
−/− 0 0 0 0
Symbols: ♀, female; ♂, male.
a Number of litter: 76; total number of mice: 443.
b Genotyping was performed by PCR at weaning.
c Expected distribution: 33% +/+ and 67% +/−; p<0.00001, χ2 test.
585M. Mbikay et al. / Developmental Biology 306 (2007) 584–5982002; Muller et al., 2000; Rehemtulla et al., 1992); it has also
been shown to inhibit PC1 enzymatic activity (Boudreault et al.,
1998; Lee et al., 2004). The P domain stabilizes the catalytic
domain of the enzyme (Ueda et al., 2003). The C-terminal
domain has been implicated in partial inhibition of PC1 activity
as well as in its sorting into secretory granules (Jutras et al.,
1997, 2000).
The related proteinase PC2 is often found in the same
granules (Kurabuchi and Tanaka, 2002; Malide et al., 1995;
Marcinkiewicz et al., 1994; Takumi et al., 1998). The activities
of the two convertases are influenced by resident granin-like
proteins: proSAAS, a competitive PC1-specific inhibitor (Basak
et al., 2001; Fricker et al., 2000; Qian et al., 2000) and pro7B2, a
PC2-specific chaperone and inhibitor (Benjannet et al., 1995;
Braks and Martens, 1994; Martens et al., 1994; Mbikay et al.,
2001; Muller et al., 1997).
PC1 and PC2 often process the same substrates, but with
cleavage site preferences. Their substrates are mostly prohor-
mones and proneuropeptides (Seidah and Chretien, 1999).
Proopiomelanocortin (POMC) and proinsulin are the best
studied of these substrates. In the anterior lobe (AL) of the
pituitary, POMC is processed primarily into adrenocorticotropic
hormone (ACTH) and β-lipotropic hormones (βLPH); in the
neurointermediate lobe (NIL), ACTH is further processed to α-
melanocyte-stimulating hormone (α-MSH) and CLIP; and
βLPH to βMSH and β-endorphin (βEND) (Chrétien and
Seidah, 1981). PC1 is most abundant in the AL; and PC2 most
abundant in the NIL (Marcinkiewicz et al., 1993; Seidah et al.,
1990, 1991). Accordingly, using co-transfected cells, it was
shown that PC1 converts POMC to peptides found in the AL
and PC2 to those found in the NIL (Benjannet et al., 1991;
Seidah et al., 1990; Zhou et al., 1993). PC1 cleaves proinsulin
after KR31–32 pair joining the B and C peptides, while PC2 does
it after the KR61–62 pair joining the C and A peptides (Smeekens
et al., 1992).
Two human cases of genetic PC1 deficiency have been
reported (Jackson et al., 1997, 2003). The first patient suffered
from massive obesity at birth and, as an adult, exhibited
hypogonadotropic hypogonadism. After treatment with gona-
dotropin-releasing hormone (GnRH), she conceived but devel-
oped gestational diabetes mellitus associated with increased
circulating levels of des-61, 62 proinsulin, suggesting that
proinsulin was cleaved by PC2 after the KR60–61 pair, but not
by PC1 after the RR30–31 pair. Genetic analyses revealed that
the patient was a PCSK1 compound heterozygote carrying, on
one allele, a splicing mutation that leads to the production of a
truncated PC1 and, on the other allele, a missense mutation that
causes a G483R substitution in the P domain of the enzyme and
retention of the latter in the ER. POMC-derived peptides
resulting from incomplete processing were detected in the
patient's serum (Jackson et al., 1997). The second patient, an
infant affected by obesity at birth and postnatal gastrointestinal
dysfunctions, was posthumously identified to be a compound
heterozygous for Ala213del and Glu250stop PC1 mutations
(Jackson et al., 2003).
A mouse model of heritable PC1 deficiency was generated
by Zhu et al. (2002b) by targeted ablation of the promoter andthe first exon of the PC1 gene. Intercross of Pcsk1+/− mice
produced offspring of all three genotypes, but homozygous
nulls were underrepresented, suggesting partial prenatal mor-
tality. Neonatal mortality of nulls was also observed. Surviving
Pcsk1−/− mice exhibited smaller birth weight and stunted
growth; they also suffered from gastrointestinal dysfunctions as
manifested by a moist texture of their stools. Growth retardation
was due to impaired processing of hypothalamic growth
hormone-releasing hormone, resulting in less plasma growth
hormone and insulin-like growth factor (IGF-1). POMC and
proinsulin processing was also impaired in these mice (Dey
et al., 2004; Marzban et al., 2004; Zhu et al., 2002a,b). A
chemically induced N222D mutation in the catalytic domain
of PC1 was recently described in mouse: homozygous
mutants develop obesity and glucose intolerance associated
with impaired processing of central and peripheral prohor-
mones and proneuropeptides (Lloyd et al., 2006).
Here, we describe another model of PC1 heritable deficiency,
generated by substituting a 32.7-kb internal region of its gene
with a 1.8 kb heterologous gene. Homozygotes for this mutation
died during preimplantation embryonic development; the
mutant allele was preferentially transmitted by heterozygous
parents and, in female heterozygotes, weight gain with age was
influenced by dietary fat content.Materials and methods
Pcsk1 disruption vector
Genomic DNA was extracted from the R1 embryonic stem (ES) cells
established from 129Sv mice. Fragments used as Pcsk1 homology regions in
the disruption vector were amplified by PCR from this DNA and cloned into
a vector previously used to disrupt the Pcsk4 locus (Mbikay et al., 1997).
The 5′ homology amplicon was amplified as a 3.2-kb fragment using the
primer pair # 1 (Supplementary Table 1); it extended from nucleotide (nt) 6 of
exon 1 to nt 77 of exon 2 (numbering based on Ensembl Pcsk1 locus ID #
ENSMUSG00000021587). It was digested at an XhoI site, located at nt 252 in
the first intron, and at a 3′-most BamHI site created with the PCR primer; the
resulting 2.7-kb fragment was cloned into corresponding sites upstream to the
neo gene for bacterial neomycin phosphotransferase II (NPTII) under the
mouse phosphoglycerate kinase 1 (PGK) promoter. The 3′ homology amplicons
was obtained using primer pair # 2 (see Table 1). It was 6.6 kb long and extended
from nt 34 in exon 10 to nt 460 of exon 13. It was digested at the 5′-most SalI
site created with the PCR primer and at a KpnI site located 0.56 kb upstream of
intron 12 acceptor splice site. The resulting 3.6-kb 5′ fragment was inserted in
the corresponding sites downstream to the neo gene and upstream of the Herpes
Simplex virus thymidine kinase (tk) gene driven by a PGK promoter. The final
vector was named pPC1KO.
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From the pPC1KO vector, a 10.4-kb insert, extending from the start of the 5′
homology region to the end of the tk gene, was excised by digestion with XhoI
and BstEII and purified. The fragment was used to produce Pcsk1+/− (+/−)
embryonic stem cells (ES) and mice, as previously described (Zhu et al., 1998).
Briefly, the DNA insert was electroporated into R1 embryonic stem (ES) cells;
clones resistant to G418 (due neo integration) and to Gancyclovir (loss of the tk
gene) were selected; Pcsk1 recombinant clones were injected into the inner mass
of blastocysts derived from C57BL/6J (B6) mice; the blastocysts were implanted
into pseudo-pregnant foster mice; male chimeric offspring were mated with B6
females to generate +/− mice. After backcrossing the mutation into the FVB/N
genetic backgrounds for 4 generations, a colony of mutant and wild-type mice
was maintained by intercrosses of the incipient congenic heterozygotes. Animal
manipulations were approved by the institutional Animal Care Committee; they
were performed following the guidelines of the Canadian Council on Animal
Care.
Blot analyses
Southern blot analysis was performed as previously described (Mbikay
et al., 1997): genomic DNA was extracted from ES cells or mouse tail tips by
proteinase K digestion followed by phenol chloroform extraction and ethanol
precipitation; it was digested with either BamHI or PstI, fractionated on
agarose gel, transferred onto a nylon membrane that was radioactively probed
for Pcsk1-specific restriction fragments. The probe for BamH1 digests was a
0.66-kb DNA fragment derived from the PC1 promoter; for PstI digests, it
was a 0.69-bp fragment derived from intron 14.
Western blot analysis was performed with chemiluminescence revelation as
previously described (St. Germain et al., 2005). Primary antibodies consisted of
rabbit antibodies against the C-terminus of PC1 (Benjannet et al., 1991, 1993),
and mouse monoclonal antibody against β-actin (Cederlane, Mississauga, ON).
Semi-quantitative densitometry of immunoreactive bands was conducted on the
ChemiGenius Bioimaging System using the Genetools software (Syngene,
Frederick, MD).
PCRs
PCR genotyping of the mice was conducted using a 3-primer set # 3 (see
Supplementary Table 1), consisting of a forward primer derived from the region
near the acceptor site of intron 1 and two reverse primers, one derived from the
3′ end of exon 2 (missing in the disrupted allele) and the other from the 5′ end of
the PGKneo gene (missing in the wild-type allele). DNA from tail tip or ear lobe
snippets was extracted as previously described (Mbikay et al., 1997).
Genotyping of individual embryos was performed using the REDExtract-N-
Amp Tissue PCR kit PCR mix as described by the manufacturer (Sigma, St.
Louis, MO).
RT–PCR was conducted as follows: total pituitary RNA was reverse-
transcribed into cDNA using dT18 primer and the Superscript II RNase H
−
Reverse Transcriptase (Gibco Life Technologies, Burlington, ON); the cDNA
was used as a template to produce PCR amplicons for PC1, PC1pro-pgkneo and
PC1pro-neo using primer pairs # 4, #5 and # 6, respectively (see Supplementary
Table 1).
Quantitative RT–PCR for the levels of PC1 and TATA box-binding protein
(TBP) mRNAs was performed using the Taqman technology (Holland et al.,
1991). Each reaction mix contained anterior pituitary cDNA as template, 1×
FastStart TaqMan Probe Master-Rox master mix (Roche, Laval, QC), a specific
primer pair and an UPL fluorogenic probes selected from the Roche Universal
Probe Library (Supplementary Table 2). The PCR was performed in a Stratagene
Mx3005P thermocycler. Standard curves were established using varying
amounts of pre-quantified amplicons of each transcript. The level of the TBP
mRNAwas used for normalization.
Peptide extraction and mass spectrometry analysis
Mouse anterior pituitary peptides/proteins were acid extracted following
the protocol of Che et al. (2005). Samples were extracted in 100 μl of 10 mMHCl by sonication three times for 5 s, followed by incubation at 70 °C for
20 min. Extracts were neutralized by addition of 100 μl 0.2 M phosphate
buffer, pH 9.5, containing protease inhibitors (Roche Complete Mini Protease
Inhibitor Tablets) and centrifuged at 50,000×g for 40 min at 4 °C. The pellets
were processed as above twice and supernatants combined. Immunoprecipita-
tion of extracted peptides/proteins were carried out in 1× Tris-buffered saline
(pH 7.6) containing 0.1% Tween (TBST). Samples were precleared by
incubation with preimmune serum in the presence of Protein A-agarose
overnight at 4 °C. They were centrifuged at 14,000×g for 2 min at 4 °C and
supernatants incubated with anti-βEND antibody as above. Following
immunocapture, the antibody–antigen complexes were washed five times in
TBST and eluted from the Protein-A beads by two successive incubations in
150 μl of 0.1 M glycine (pH 2.8) for 10 min at room temperature with shaking.
Supernatants were collected, combined and neutralized with 30 μl of 1 M
Tris–HCl (pH 9.0). The eluates were equilibrated in 20% acetonitrile (ACN)/
0.1% trifluoroacetic acid (TFA) with an Amicon Ultra YM3 Centricon
(Millipore Corp., Bedford, MA), lyophilized and solubilized in 5 μl of 20%
ACN+0.1% TFA. For time-of-flight mass spectral analysis, 2.5 μl of each
sample were applied twice to a spot on a gold ProteinChip Array (Ciphergen
Biosystems Inc, Palo Alto, CA) and allowed to air dry at room temperature
after each application; 1 μl of saturated 3,5-dimethoxy-4-hydroxycinnamic
acid (SPA) in 50% ACN+0.5% TFA was added to each spot. Mass spectral
analysis was performed by time-of-flight mass spectrometry in a Ciphergen
Protein Biology System II (PBS II). Analyses represent an average of
100 shots. Masses were calibrated externally with All-in-1 Peptide Standards
(Ciphergen Biosystems Inc.). All data were normalized for total ion current
and peak areas calculated using the indirect method (with a bracket height of
0.4 and width expansion factor of 2) contained within Ciphergen's ProteinChip
Software 3.1.
Embryo culture
Superovulation was induced in female mice by intraperitoneal injection (i.p.)
of 5 international units (IU) of pregnant mare serum gonadotropin (PMSG)
followed, 48 h later, by 5 IU human chorionic gonadotropin (hCG). The mice
were placed with males overnight to mate; mating was ascertained the next day
by the presence of a vaginal plug. The mice were sacrificed by cervical
dislocation. Eggs and embryos were collected from the oviduct into a drop of
KSOM medium (95 mM NaCl, 2.5 mM KCl, 0.35 mM KH2PO4, 0.2 mM
MgSO4·7H2O, 10 mMNa lactate, 0.2 mM glucose, 0.2 mMNa-pyruvate, 4 mM
NaHCO3, 1.7 mM CaCl2·2H2O, 1 mM glutamine, 0.01 mM EDTA, 240 mosM,
0.16 mM K-penicillin G, 0.03 mM streptomycin sulfate) containing 21 mM
HEPES and 0.01% polyvinyl alcohol (HEPES/KSOM/PVA) as well as 1 mg/ml
hyaluronidase, washed through successive transfer into 1 drop of fresh HEPES–
KSOM/PVA and 3 drops KSOM/PVA under mineral oil (Lawitts and Biggers,
1993). They were incubated in the last drop at 37 °C under a 5% CO2/95% air
atmosphere for up to 6 days. Alternatively, unfertilized eggs were collected 24 h
post hCG from females that were superovulated but not mated; 1-cell, 2-cell, 6/
8-cell, morula and blastocysts were collected from superovulated and mated
females, 28, 32, 72, 98 and 120 h post hCG, respectively.
Expression vectors and transfection
The 1.1-kb PC1pro-neo cDNA amplified by RT–PCR from pituitary RNA
of Pcsk1+/− mice was first subcloned into pCR4TOPO plasmid (Invitrogen,
Burlington, ON); it was then excised from this vector with SpeI and NotI and
transferred directionally between NheI and NotI sites into the pCIneo eukaryotic
expression vector (Promega, Ottawa, ON), under the human cytomegalovirus
promoter–enhancer to generate the pCIneo/PC1pro-neo vector. Similarly, a
7B2-expression vector was made by inserting the full-length cDNA for rat 7B2
between the same two restriction sites.
For transfection, human embryonic kidney HEK293 cells were seeded into
6-well plates at a density of 7.5×105 per well in DMEM containing 10% fetal
bovine serum (FBS); they were cultured to 75% confluence in a 5% CO2–95%
air atmosphere at 37 °C; they were then transfected in triplicate with 1 μg of a
single or mixed vector DNA using Lipofectamine Reagent liposomes as
specified by the manufacturer (Life Technologies, Burlington, ON); they were
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cysteine.
Metabolic labeling and immunoprecipitation
Transfected HEK293 cells were rinsed twice with phosphate-buffered saline
(PBS), layered with 1 ml/well of methionine and cysteine-free RPMI medium
(ICN Biomedicals, Nepean, ON) and incubated at 37 °C for 30 min to deplete
endogenous methionine. RPMI medium containing 250 μCi of 35S-methionine–
cysteine/ml/well was substituted and incubation was resumed for 2 h. Spent
media were collected and cells were scraped off the dishes into 400 μl of RIPA
buffer (50 mM Tris–HCl, 1% Nonidet P-40, 0.5% sodium deoxycholate,
150 mM NaCl, 1% SDS). Media and cell lysates were supplemented with
0.04 volumes of a complete protease inhibitor cocktail (Boerhinger Manheim,
Laval, QC; 25× stock solution: 1 tablet/2 ml). They were vigorously mixed on a
vortex for 2 min, placed on ice for 30 min and centrifuged at 10,000×g for
10 min at 4 °C. Supernatants were collected and each was supplemented with
2 μl of normal rabbit serum and 15 μl of a 50% (w/v) suspension of Protein A-
agarose. After a 1-h incubation at 4 °C with rotational mixing, the samples were
centrifuged at 3000×g for 5 min at 4 °C. Supernatants were collected and each
was supplemented 5 μl of rabbit anti-7B2 (Paquet et al., 1994) or anti-NPTII
antibody (Sigma). They were incubated with mixing as above. The resin with
bound immune complexes was then sedimented by centrifugation as above,
rinsed three times with RIPA buffer, twice with a buffer containing 1 M NaCl,
10 mM Tris–HCl and 1 mM EDTA, pH 8, and twice with PBS containing 1 mM
EDTA. Pellets were suspended in 25 μl of 1× Laemmli buffer each, boiled for
5 min, and sedimented as above. Supernatant was subjected to electrophoresis
through polyacrylamide gels (8 or 12%). Gels were fixed for 30 min in a 50%
methanol–10% acetic acid solution, treated for 30 min with Amplify fluor
solution (Amersham Biosciences, Baie d'Urfé, QC), dried under vacuum and
exposed to phosphorimaging screen overnight. Specific radioactive proteinFig. 1. Production and screening of Pcsk1mutant mice. (A) The wild-type allele (+), t
are diagrammatical depicted. The BamH1 fragments generated detectable by Sout
disrupted allele (8 kb). The 3-primer set # 3 used for PCR genotyping (see Table 1) ar
the 3′ intron 1 forward primer; the white leftward-pointing arrowheads for reverse pr
PGK reverse primer. (B) Southern blot analysis of genomic DNA from offspring of
bands represent the disrupted (−) and wild-type (+) Pcsk1 alleles, respectively. (C) Tbands were visualized and quantified on a Typhoon Phosphorimager (Molecular
Dynamics, Sunnyvale, CA).
Feeding, weight and plasma glucose
Four-week-old mice were divided into groups (n=6/gender/genotype) that
were fed either a low-fat diet (LFD) or a high-fat diet (HFD) (diets no. D12450
or no D12451, respectively, obtained Research Diet, North Brunswick, NJ); the
LFD contained 10% kcal and the HFD 45% kcal as fat. Body weight was
recorded weekly. After 13 weeks, the mice were fasted for 16 h, anesthetized
with isoflurane (Abbott Laboratories, Montreal, QC) and bled by heart puncture.
Some mice were i.p. injected with glucose (1.5 mg/g body weight) and blood
collected as above 10 or 60 min later. Plasma was separated from blood cells by
centrifugation 600×g for 10 min. Plasma glucose was determined using a
glucose analyzer (Beckman Coulter, Fullerton, CA).
Statistics
Significance was determined by unpaired Student's t test.Results
Production and analysis of Pcsk1 mutant mouse
The disruption vector is shown in Fig. 1A. Homologous
recombination between this vector and the Pcsk1 locus should
result in the excision of 32.7 kb of internal domain including
exon 3 to exon 9. The recombination construct was excisedhe disruption vector and the disrupted allele (−) after homologous recombination
hern blot analysis is shown above the wild-type allele (15 kb) and below the
e represented by arrowheads: the black rightward-pointing arrowhead stands for
imers, the white one for the 5′ exon 2 reverse primer and the grey one for the 5′
heterozygous intercross using a probe derived from exon 1. The 8 kb and 15 kb
riplex PCR of the same genomic DNA using the 3-primer set # 3.
Table 2
Genotype distribution among preimplantation embryos from heterozygote
intercrosses
Embryo st a Total Number of embryos per Pcsk1 genotype
(%)
+/+ +/− −/−
1-cell 22 8 (36) 7 (32) 7 (32)
2-cell 32 8 (25) 18 (56) 6 (19)
4-cell 20 8 (40) 11 (55) 1 (5)
6- to 8-cell 37 6 (16) 30 (81) 1 (3)
Morula 24 2 (8) 22 (92) 0 (0)
Blastocyst 56 6 (11) 50 (89) 0 (0)
E7.5 37 1 (3) 36 (97) 0 (0)
E15–E16 26 2 (8) 24 (92) 0 (0)
a E, embryonic day.
Table 3
Genotype distribution among the offspring of wild-type to heterozygote
reciprocal crossesa
Parental genotype N a Offspring genotype b
♀ × ♂ +/+ (%) +/− (%)
+/+ × +/− 17 35 (40) 52 (60)
+/− × +/+ 9 16 (33) 33 (67)
a Number of litter.
b Expected distribution: 1:1, p<0.01, χ2 test.
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selected for resistance to G418 and Gancyclovir; they were
screened by Western blotting for the anticipated BamH1 and
PstI, fragments using probes derived from the promoter and
from exon 14, respectively (not shown).
Two clones showing the expected restriction fragment
patterns were injected into B6 blastocysts; the latter were
implanted into foster female mice; male chimeric mice born
from these foster mothers were crossed with B6 females to
produce offspring that are heterozygous for the Pcsk1 deletion–
insertion (+/−). These were identified either by Southern
blotting analysis of BamH1 digests (Fig. 1B) or by triplex
PCR (Fig. 1C) of tail-tip genomic DNA.
Homozygote lethality and transmission ratio distortion
When +/− mice were intercrossed, no homozygous Pcsk1
mutant (−/−) mice were obtained (Table 1). Genotyping of
preimplantation embryos derived from these crosses revealed
the presence of a significant percentage of −/− embryos at the 1-Fig. 2. In vitro development of preimplantation embryos from Pcsk1+/+ and Pcsk1
genotype: +/+×+/+ are labeled as +/+ and +/−×+/− as +/−. Fertilized eggs were colle
coitus; c. morula, compacted morula; blasts, blastocysts.cell (31%) and 2-cell (19%) stages; this percentage was below
5% at 4-cell and 8-cell stages and 0% at later stages (Table 2),
suggesting that lethality occurred after the second embryonic
division. Interestingly, the frequency of the mutant allele among
surviving late preimplantation (morula to blastocysts), post-
implantation and weanlings was consistently ≥80% instead of
the 66.7% expected (p<0.0001, by χ2) (Tables 2 and 3), an
indication of preferential transmission of this allele. This
preference was still observed in +/+×+/− reciprocal crosses
(Table 3), excluding any parental origin effect.
To determine whether the lethality of −/− preimplantation
embryos was due to intrinsic developmental failure, we cultured
fertilized eggs from +/+×+/+ and +/−×+/− crosses and
followed their growth for 6 days. We reasoned that death of
−/− embryos resulting from heterozygote intercrosses should be
reflected by a significant decrease in the number of living
embryos at some stage past the second cell division. The results
are shown in Fig. 2. Most embryos looked morphologically
healthy on day 6 (93%, n=88 for +/+×+/+ crosses and 98%,
n=83 for +/−×+/− crosses, hereafter called mixed embryos).
However, the growth pattern were distinct: on day 2, all the
fertilized eggs reached the 2-cell stage; but on day 3, 45% of the
+/+ embryos and only 22% of mixed embryos reached the
morula stage; on day 4, the latter caught up with the +/+ as all
becamemorula; but they grew slightly faster on the 2 subsequent
days, with 79% reaching the blastocyst stages (vs. 67% for +/++/− intercrosses. Superovulated female mice were mated to males of the same
cted, cultured and scored on a daily basis for developmental stage. dpc, day post-
Fig. 3. Identification and characterization of aberrant mRNAs transcribed from
the mutant allele. (A) Diagrammatic representation of the 5′ region of the wild-
type (+) and disrupted (−) Pcsk1 allele with below the expected transcript
represented below. Intron 1 splicing out is represented with broken lines; primer
regions with inverted flags. The prefix “e” in e1, e2 etc stand for exon. (B)
Agarose gel analysis of RT–PCR amplicons from pituitary RNA from +/+
and +/− male mice, using primer pairs # 4 and # 5.
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day 6, respectively. All three genotypes were detectable by PCR
among blastocysts from heterozygote intercrosses. The survival
of −/− embryos in culture suggests that their lethality in vivo
may be caused by negative selection in the oviductal
environment.
Expression of an aberrant PC1neo fusion mRNA
In the mouse model of targeted inactivation of the Pcsk1
locus reported by Zhu et al. (2002b), the promoter and the first
exon were ablated; prenatal and perinatal lethality of homo-
zygous mutants was observed, but nearly 33% of them survived
to adulthood. In an attempt to explain the preimplantation
lethality of our model, we examined the possibility that the PC1
promoter in the mutant allele could drive the production an
aberrant mRNA and protein that could aggravate the phenotype.
A potential primary transcript of the mutant locus would include
exon 1, intron 1, a 5′ fragment of exon 2 and the PGKneo
sequence down to the polyadenylation signal. After removal ofintron 1, this transcript should generate an mRNA with open
reading frame (ORF) specifying the signal peptide and an N-
terminal propeptide segment of PC1 fused to an extension of
indeterminate size (Fig. 3A).
To verify whether such an mRNA was produced, we
conducted an RT–PCR on pituitary mRNA from +/+ and +/−
mice using primer pair # 4 for wild-type PC1 mRNA or
primer pair #5 for the putative PC1neo fusion mRNA. The
pituitary was selected as source of RNA because it expresses
high levels of PC1 (Seidah et al., 1990, 1994), a reflection of
PC1 gene promoter activity. Polyadenylated RNA was
specifically reverse-transcribed into cDNA using an oligo-dT
primer. The RT–PCR results are shown in Fig. 3B. With
primer pair #4, the expected amplicon of 278 bp was detected
in both samples (lanes 2 and 3). In contrast, using primer pair
#5, the expected amplicon of 354 bp was obtained from +/−
pituitaries (lane 5), but not from +/+ pituitaries (lane 4),
confirming the existence of the aberrant mRNA. This mRNA
was also detectable in pools of unfertilized eggs, fertilized
eggs and preimplantation embryos obtained from +/− inter-
crosses (not shown).
To establish the full sequence of these transcripts, oligo-
dT-primed cDNA from +/− mouse pituitary RNA was
subjected to long-range PCR using a forward primer derived
from the region upstream to the initiator ATG in PC1 exon 1
and a reverse primer from the neo mRNA 3′-UTR (primer
pair #6). Three cDNA amplicons of 1.6, 1.4 and 1.1 were
obtained and sequenced (Fig. 4A). They corresponded to
alternate splice variants of the primary transcript. The
predictability of the splice sites were confirmed a posteriori
using the NNSPLICE 0.9 version algorithm (Reese et al.,
1997) online (http://www.fruitfly.org/seq_tools/splice.html).
The 1.6-kb and 1.4 amplicons encoded a fusion protein
made of the 27-amino acid (aa) signal peptide and the first 58
aa of the propeptide of PC1 followed by a 48-aa extension
encoded by the PGK sequence (not shown). The 1.1
amplicons specified a single ORF consisting of the same
85-aa PC1 prepropeptide fused to the full NPTII sequence by
a 12-aa joining peptide (Fig. 4B). This amplicon was cloned
into the PCIneo expression vector and the resulting vector
was transiently transfected into HEK293 cells. Metabolic
labeling followed by NPTII-specific immunoprecipitation and
SDS–PAGE revealed the presence of the PC1pro-NPTII
(∼37 kDa) and a processed NPTII (∼27 kDa) in cell extracts
and media (Fig. 4C, lanes 2 and 4). The size of secreted
NPTII was smaller than predicted for NPTII (∼32 kDa) if the
propeptide was the only segment removed, suggesting that the
mature protein underwent other forms of proteolytic proces-
sing in the secretory pathway. A 68-kDa protein was co-
immunoprecipitated with the NPTII-related proteins from
cells expressing the fusion protein (lane 2); its identity is
unknown.
Inhibitory activity of aberrant mRNA translational products
The precursor for the neuroendocrine protein 7B2 is a model
substrate for testing proprotein convertase activity ex vivo.
Fig. 4. Full-length aberrant mRNAs from the mutant allele. (A) Diagrammatic
representation of the 5′ region of the disrupted Pcsk1 allele. RNAwas extracted
from the pituitary of +/− male mice and subjected to long-range RT–PCR using
primer pair # 6 are shown. Agarose gel pattern of the resulting amplicons is
below at the right of their diagrammatical representation. Splicing events
deduced from the sequence of the transcripts are represented with broken lines;
and primer regions with inverted flags. The prefix “e” in e1, e2, etc., stands for
exon. (B) Amino acid sequence of the protein specified by the 1.1 cDNA
amplicon: the PC1 sequence includes the signal peptide and the first half of the
propeptide (underlined); it is followed by a joining peptide (bold and italics), and
the NPTII sequence. The furin recognition site in the propeptide region is bolded
and boxed. (C) Expression and processing of PC1prepro-NPTII in transfected
HEK293 cells. Cells transfected with the specified expression vector were
metabolically labeled with 35S-methionine and NPTII proteins analyzed by
immunoprecipitation and SDS–PAGE. Proteins derived from the PC1prepro-
NPTII are identified with arrowheads (cells) and arrows (medium). An
intracellular protein that co-immunoprecipitates with the fusion protein is
indicated with a star.
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more of the paired basic residues located in the C-terminal
region, generating a pattern of processed products that differ
among cell lines (Benjannet et al., 1997). The expected
fragments are diagrammatically represented in Fig. 5A.To determine whether the PC1pro-NPTII could affect
pro7B2 processing, we transiently co-transfected expression
vectors for this aberrant protein and for pro7B2 into HEK293
cells. These cells express furin, PACE4, PC5 and PC7 (Tsuji et
al., 2002). The cells were metabolically labeled and 7B2-related
proteins were identified following immunoprecipitation, SDS–
PAGE and phosphorimaging. 7B2-immunoreactive proteins of
estimated molecular weights of 30, 28, 25 and 23 kDa were
observed (Fig. 5B); they presumably correspond to 7B21–186,
7B21–171, 7B21–161 and 7B21–150, respectively (see Fig. 5A).
7B21–161 and 7B21–150 are the major secreted forms. The
relative abundance of each 7B2 form (% of total) is shown in
Fig. 5C. Of all the forms, only the 28-kDa 7B21–171 form was
significantly reduced in the presence PC1pro-NTPII. PC5A has
been shown to generate this form when co-expressed with
pro7B2 in monkey kidney BSC40 cells (Benjannet et al., 1997).
These results support the possibility that, in +/− early embryos,
aberrant products from the Pcsk1 mutant allele could reduce
proteolytic activation of precursors to functional proteins or
peptides by broader inhibition of proprotein convertases
activities.
Reduced PC1 expression in the anterior pituitary of
Pcsk1+/− mice
PC1 expression in the anterior lobe of the pituitary of +/+
and +/−mice was compared at the mRNA and protein levels. We
chose this lobe because it is the primary site of PC1 expression in
this organ (Seidah et al., 1990). Quantitative RT–PCR analysis
was conducted using a primer pair that will amplify transcripts
from the wild-type Pcsk1 allele only. The anterior pituitary
content of PC1 mRNAwas comparable between genotypes and
between genders. There was a trend towards greater PC1 mRNA
levels expression in males than in females of the same genotype
(Fig. 6A).
A semi-quantitative immunoblotting of anterior pituitary
extracts from +/+ and +/− male mice was conducted using an
antibody against a C-terminal fragment of PC1 (identified in Fig.
6B-a). In both genotypes, this antibody recognized a ∼80-kDa
and a ∼20-kDa forms, presumably representing mature
PC11–643 and the C-terminal peptide PC1-CT509–643 (Fig. 6B-b).
However, the two PC1 fragments were significantly less
abundant in anterior pituitary extracts from +/− mice (p<0.01,
n=4) (Figs. 6B-b and c).
Using mass spectrometry (MS), we analyzed the relative
abundance of POMC-derived peptides immunoprecipitated
with the anti-βEND antibody from acid extracts of anterior
pituitaries from males and female mice of both genotypes.
Representative MS profiles of these peptides are shown in Fig.
7A. The identities of the peptides specifically immunoprecipi-
tated are provided in Fig. 7B. The identification was based on
the close proximity between the expected and the observed
molecular masses of the peptides (Supplementary Fig. 1). The
MS profiles significantly differed between male and female
mice, with males producing more βEND and less βLPH than
females. However, within each gender, there was no significant
difference between +/+ and +/− mice (Fig. 7C).
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mice
Genetic PC1 deficiency in human causes congenital obesity
(Jackson et al., 1997). A similar phenotype was observed in the
recently reported Pcsk1N222D/N222D mouse (Lloyd et al., 2006).
In the mouse model lacking the promoter and exon 1 of the
Pcsk1 gene (Zhu et al., 2002b), it leads to reduced body mass
and weight gain with age, relative to +/+ mice, but causes a
trend towards greater weight gain in +/− mice. In our model, no
significant difference in these parameters was observed between
the two genotypes when mice were fed normal chow (not
shown). However, when the effect of low-fat diet (LFD) or
high-fat diet (HFD) on weight gain with age was examined,
some differences were noted (Fig. 8, n=6 per group). At
4 weeks of age, mice of the same gender were of comparable
weight, irrespective of the genotype (26.5±1.1 g for +/+ vs.Fig. 5. Inhibition of pro7B2 processing by PC1pro-NPTII. (A) Diagrammatic represen
bars). The basic residues preceding the cleavage sites are given on top of the top bar. T
end of each bar, respectively, taking into account carboxypeptidase (CP)-mediated re
terminal Gly followed CP action. The apparent molecular masses of these forms are
pCIneo vector or a mixture of equal amounts of pCIneo and pCIneo-7B2 or of pCIne
35S-methionine/cysteine. Cell extracts and spent media were analyzed for 7B
phosphorimaging. The 7B21–171 processed form affected by PC1pro-NPTII expr
relative abundance of 7B2 forms in the absence (open boxes) or in the presence (filled
of 7B2 forms and standard errors of these means (SEM), respectively. The experim27.1±1.0 g for +/− males; 21.0±0.4 g for +/+ vs. 21.0±0.9 g
for +/− females). After 13 weeks of LFD, male mice of both
genotypes gained comparable amount of weight (23% for +/+
mice vs. +25% for +/− mice); but +/− female mice gained
significantly less (9%) weight than their +/+ counterparts
(26%). After 13 weeks of HFD, male mice of both genotypes
gained more weight than those under LFD (40% vs. 23% for
+/+ mice; 33% vs. 25% for +/− mice). In contrast, female
mice responded differently to the increase in dietary fat
intake: whereas +/+ were insensitive to it, gaining the same
amount of weight (23%) under either diet, +/− mice, on the
other hand, were highly sensitive to it, gaining 43% more
weight under HFD compared to 9% more under LFD. Plots of
weights with increasing age under the two diets per gender
and per genotypes are provided as Supplementary Fig. 3.
These results suggested that the mutation at the Pcsk1 locus
affected female body response to dietary fat content.tation of pro7B2 (top bar) and of known products of its processing by PCs (lower
he number of the first and last residue of each form is indicated at the start and the
moval of terminal basic residues after PC cleavage, and amide conversion of the
given at the right under kDa. (B) Cells were transfected with 1 μg of DNA of
o-7B2 and pCIneo-PC1pro-neo; 48 h later, they were metabolically labeled with
2 forms by immunoprecipitation and SDS–PAGE and semi-quantitative
ession is identified with an arrowhead. (C) Histogram representation of the
boxes) of PC1pro-NPTII. Box heights and error bars represent mean percentages
ent was conducted in triplicate. *p<0.01.
Fig. 6. PC1 expression in anterior pituitaries from individual +/+ and +/− mice. (A) The levels of mRNA for PC1 and TBP were determined by Taqman qRT–PCR
using primer pairs and fluorogenic probes described in Supplementary Table 2. The forward and reverse primers for PC1 were derived from exon 6 and exon 7,
respectively. They should amplify transcripts from the wild-type allele only since the recognized region was ablated in the disrupted allele. The relative levels of PC1
mRNAwere derived after normalization for the levels of TBP mRNA. Values represent means of PC1/TBP ratios±SEM. There was no significant difference between
same-gender +/+ and +/− mice. Among +/+ mice, however,♂ mice contained significantly more PC1 mRNA in their anterior pituitary than ♀ mice (n=6). (B) (a)
Diagrammatic representation of PC1 domains. The protein is represented as horizontal box, with the prodomain (pro), the fully mature enzyme (PC1) and
the C-terminal domain (CT) differentially colored. The P4–P1′ amino acid sequences encompassing the cleavage sites (↓) are shown above the box. The position of the
CT antigen used for raise the antibody used in this analysis is shown as a line below the box. (b) Western blot analysis of proteins extracted from anterior pituitaries of
individualmalemice. Samples were fractionated by 10–20%SDS–PAGE.Membranes were probedwith the anti-PC1-CT (upper panel), or an anti-β actin (lower panel)
antibody. (c) Comparison of levels of PC1 and PC1-CT peptide. Densities of immunoreactive PC1 bands in (b) were normalized for the cognate densities of the β actin
bands. Values represent means of PC1/TBP ratios±SEM (n=4). Compared to +/+ mice, +/− mice contained in 31% and 54% less anterior pituitary PC1 and PC-CT
peptide, respectively (*p<0.01).
592 M. Mbikay et al. / Developmental Biology 306 (2007) 584–598There were no statistical differences between +/+ and +/−
mice (n=4/gender/genotype) in fasting glycemia (g/l) after
13 weeks of LFD (98.3±18.6 vs. 92±17.5 for males and 98.3±
18.6 vs. 92±17.5 for females) and HFD (124±11.9 vs. 103±
21.7 for males and 98.3±18.6 vs. 92±17.5 for females) as well
as in glycemic response to intraperitoneal glucose injection (not
shown), suggesting that the mutation did not induce any
significant disturbance of glucose homeostasis.
Discussion
In this report, we have described a mouse model of
targeted inactivation of the PC1 gene by a deletion/insertion.
The deletion was about 32.7-kb long; it removed about three
quarters of the structural gene, from exon 2 to exon 10. Theinsertion was a 1.8-kb PGKneo gene. This deletion/insertion
caused a complex phenotype consisting of preimplantation
lethality of homozygous mutants, preferential transmission of
the mutant allele and susceptibility of heterozygous female
mice to dietary fat content. We examined the possibility that
the disrupted Pcsk1 region contained any nested genes (Yu et
al., 2005) or regulatory mRNAs (Alvarez-Garcia and Miska,
2005), the loss of which might be invoked to explain this
phenotype. Analysis of the deleted genomic region using the
GeneComber algorithm (http://www.bioinformatics.ubc.ca)
revealed two short nested genes specifying peptides with
no significant homology with any known protein. A
TargetScan search (http://www.targetscan.org) also failed to
identify any potential microRNA sequence or target in the
disrupted region.
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was observed among N4 incipient congenic mice of either FVB/
N or B6 genetic background. Its causes are still uncertain.
Homozygote preimplantation lethality in mouse has generally
been associated with intrinsic defects, caused by spontaneous or
induced genetic lesions. One example of spontaneous lesions is
the lethal yellow (Ay) mutation, a 170-kb deletion at the mouse
agouti (a) locus on Chr 2 (Rinchik et al., 1993). Examples of
induced lesions include knockout mice for the mixed lineage
leukemia (MLL) gene whose product regulates Hox gene
expression (Ayton et al., 2001), for the xeroderma pigmento-Fig. 7. Mass spectrometry of POMC-derived peptides from the anterior pituitary o
antibody (Ab) from acid extracts of individual anterior pituitaries from ♀ and♂ mic
masses of the βEND-specific immunoreactive peptides [(a) and (b)] from ♀ (a) and♂
from ♀/+/+ mice (c). (B) Schematic representation of major POMC-derived peptide
provided the P4–P1 tetrapeptide ending with a pair of basic residues. The numbers o
below the boxes. Their identities and their expected masses are specified at the right a
flanked by the > or < symbol, respectively. (C) Levels of peptides in each sample wer
presented mean percentages±SEM. The number of mice (n) used was 7 for♀+/+ and
♂ and ♀ mice are indicated in the upper panel as *p<0.5, **p<0.005 or ***p<0.sum-associated genes such as the XPD gene (de Boer et al.,
1998) and the XAB2 gene (Yonemasu et al., 2005). In some of
these genetic lesions, gene ablation was associated with
expression of aberrant transcripts that may have contributed to
the lethal phenotype. In the Ay mutant mouse, for example, the
deletion ablates the structural gene for Raly, placing the agouti
gene under the Raly gene promoter and causing ubiquitous
expression of this normally neonatal skin-restricted gene. The
Raly gene specifies an RNA binding protein critical for early
growth. Thus, the Ay phenotype results from both Raly gene
ablation and ectopic expression of the agouti gene (Duhl et al.,f +/+ and +/− mice. Peptides were immunoprecipitated (IP) with anti-βEND
e. (A) Typical profiles of time-of-flight mass spectral analyses of the molecular
(b) mice or non-specific peptides immunoprecipitated by a preimmune serum
s. POMC is represented as a succession of horizontal boxes. Above the bar are
f P1 residues are indicated. Detected processed peptides are represented as lines
nd the left, respectively. Peptides more or less abundant in ♀ than in♂mice are
e calculated relative to the total ion current and peak areas set as 100%. They are
♂+/−mice; 6 for♀+/− female and♂+/+ mice). Significant differences between
0005.
Fig. 7 (continued).
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MLL-null mice, the mutant allele expresses truncated in-frame
Mll transcripts which encode functional domains of the protein
(Ayton et al., 2001).
The Pcsk1 mutation described in this study also causes both
gross genetic alterations and production of aberrant transcripts.
However, it is unlikely that these structural and expression
abnormalities in the mutant allele are the sole determinants of
the preimplantation lethality of −/− embryos in vivo, since
nearly all fertilized eggs from heterozygote intercrosses can
develop to the blastocyst stage in vitro (Fig. 2). The growth
pattern of these embryos in culture revealed a transient growth
delay from the 4-cell to the morula stage, suggesting that this
could be the stage of greater vulnerability for the −/− embryos.
This is partially supported by the genotyping results of in vivo-
grown embryos which show a sharp drop in the frequency
of −/− embryos after the second cell division (Table 3). The
lethality of these embryos in vivo may be due to a deficiency for
autocrine factors needed to survive under the selective
environment of the oviduct. This deficiency may be relieved
in vitro through factor sharing among embryos. It is known that
low-density culture of mouse fertilized eggs impairs their
development to the blastocyst stage. This impairment can be
partially corrected by supplementation of bioactive peptide such
as epidermal growth factor (EGF), transforming growth factor
(TGF) α or β1 or platelet-activating factor (O'Neill, 1998; Paria
and Dey, 1990).
We have recently shown that transcripts for all PCs, except
PC2, are found in fertilized eggs. Expression of PC1, furin,
PACE4 and PC7 is maintained during development to theblastocyst stage, while that for PC4 and PC5 gradually subsides
(St. Germain et al., 2005). These enzymes may be involved in
the proteolytic activation of a number of precursors to autocrine
factors and their receptors. The embryo and the oviduct produce
several factors through this process, among them, GnRH (Casan
et al., 1999, 2000; Kawamura et al., 2005; Raga et al., 1999),
IGF-1 and-2, IGF-1 receptor (IGF-1R) and TGFβ1–3 (Dalton
et al., 1994; Doherty et al., 1994; Lighten et al., 1997). GnRH
and IGF-1 have been shown to act as anti-apoptotic agents on
embryos in culture (Fabian et al., 2004; Jousan and Hansen,
2004; Kawamura et al., 2005).
PC1 deficiency in the mutant embryos will undoubtedly lead
to impaired processing of precursors to some of these factors.
However, considering the overlap in cleavage specificity among
PCs (Seidah and Chretien, 1999; Steiner, 1998), furin, PC7 and
PACE4 which are expressed throughout preimplantation
embryonic development (St. Germain et al., 2005), should be
able to partially compensate for this deficiency. The fact that −/−
preimplantation embryos survive in the mouse model generated
by Zhu et al. (2002b) would support such a view. We speculate
that, in our model, the deficit of autocrine factors may be
aggravated by a more generalized inhibition of PCs caused by
secretory truncated PC1 propeptides produced in −/− embryos.
Propeptides derived from the prodomain of PC1 have been
shown to inhibit not only PC1, but also furin, PC5 and PC7
(Basak and Lazure, 2003; Boudreault et al., 1998; Fugere et al.,
2002). It is interesting to note that embryonic lethality of −/−
became noticeable after the 4-cell stage, when degradation of
egg-derived mRNAs is virtually complete and activation of the
zygotic genome has been initiated (Wang and Dey, 2006). At this
Fig. 8. Effect of dietary fat on age-related weight gain. From 4 to 17 weeks of
age, ♂ and ♀, wild-type (+/+, white bars) and mutant (+/−, black bars) mice
(n=6/genotype/gender) were fed either a low fat diet (LFD) or a high fat (HFD);
they were weighed on a weekly basis. The results are presented histographically
as mean body weights (g)±SEM.Mouse ages in weeks at the start and the end of
the protocol are indicated within the histographic boxes. The % weight gains at
the end of the protocol are indicated .above each box. Significant differences in
weight gain between +/+ and +/− mice are indicated above the corresponding
boxes as **p<0.001.
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production and accumulation of the PC1 propeptide fusion
proteins with broad inhibitory activity against PCs. This
Pcsk1−/− mouse may therefore represent a model of multiple
convertase deficiency. The model suggests that drug-mediated
broad inhibition of PCs could cause early arrest of pre-
implantation embryo development.
Another striking feature of this model is the non-Mendelian,
higher frequency of the mutant allele among offspring of all
cross combinations. The transmission ratio distortion (TDR)
became detectable at the 6- to 8-cell stage of embryonic
development and persisted to birth. One of the most examined
cases of transmission ratio distortion (TDR) in mouse is the t-complex inversion on Chr 17. In this mouse, the mutant allele is
transmitted to up to 95% of the offspring of t/+ males to +/+
female crosses, due to damaging effect of gene products from
the t-complex on + sperm during meiosis (Lyon, 2003). Another
well-documented case of TDR in mouse is associated with the
Om mutation on Chr 11. In this case, TDR was observed in
the offspring of reciprocal backcrosses of (B6×DDK)F1 to
either parental strain, with preferential transmission of the DDK
Om allele when F1 females were mated to B6 males. The
distortion has been attributed to meiotic drive leading to
preferential segregation of the wild-type chromatids to the polar
body during the second meiotic division, leaving the mutant
chromatids to contribute to the zygote genome (Wu et al.,
2005). The TDR observed with our Pcsk1+/− mouse model
cannot be explained through either of these meiotic events since
it was absent at the 2-cell stage. It is unclear at present whether
the distortion is due to a greater survival of +/− embryos or a
greater lethality of +/+ embryos, under the selective pressure of
the oviductal environment.
In humans, total PC1 deficiency is associated with increased
body mass at birth (Jackson et al., 1997). The opposite is
observed in PC1-null mice generated by Zhu et al. (2002b). In
this mouse model, however, +/− mice gained more weight with
age than +/+ mice. In another mouse model of partial PC1
deficiency, a homozygous phenotype of obesity and hyperpha-
gia was reported (Lloyd et al., 2006). In our model, there was no
difference between +/+ and +/− mice of the same gender in
weaning weight or age-related weight gain under normal chow.
The difference between the three models could be due to
differences in genetic backgrounds as well as in the nature of the
mutations. The influence of genetic background on the morbid
phenotype was illustrated in a comparative study of mice
carrying a targeted inactivation mutation in the Pcsk2 and
Sgne1 genes, specifying PC2 and its helper protein 7B2,
respectively: both mutations lead to a Cushing-like syndrome in
the 129Sv genetic background, but not the B6 one (Peinado
et al., 2005).
In the mouse model of PC1 deficiency described in this
study, age-induced weight gain is susceptible to dietary fat in
female mice: compared to +/+ mice, −/− mice experienced
stunted growth under a LFD and catch up growth under HFD.
This differential response dietary fat cannot be attributed to
differences in appetite since there was no significant difference
in food intake between genotypes when mice were fed either a
low-fat or a high-fat diet (Supplementary Fig. 3). It was not
observed among male mice. The physiological basis for the
phenotypic gender dichotomy is unclear. We have observed that
the profiles of anterior pituitary POMC-derived peptides were
consistently different between male and female mice (Fig. 7).
Although these profiles were similar between +/+ and +/− in
this tissue, it remains possible that other precursors in other
tissues might be differentially processed. The weak inhibitory
activity of the aberrant proteins on PC1-mediated processing of
pro7B2 in transfected cells (Fig. 5) is not a compelling
argument for an in vivo effect. The putative toxicity of these
proteins in early development may be unrelated to this activity.
Alternatively, it may be due to derangement of macromolecule
596 M. Mbikay et al. / Developmental Biology 306 (2007) 584–598interactions and dynamics. To explain the greater susceptibility
to PC1-deficient female mice to dietary fat, it will be necessary
to examine whether the normal levels of PC1 enzymatic activity
differs between genders and whether this is associated with
differences in PC1-mediated production of central and periph-
eral peptide hormones and neuropeptides that control nutrient
absorption and metabolism.
In summary, we have described a mouse model of heritable
PC1 deficiency caused by a deletion/insertion at the Pcsk1
locus and associated with homozygote preimplantation lethality,
preferential transmission of the mutant allele and female
heterozygote susceptibility to dietary fat.
Acknowledgments
The authors are indebted to Mrs. Adrianna Gambarotta,
Josée Hamelin, Haidy Tadros, Jennifer Hazelwood and Mr.
Andrew Chen for their technical assistance. This work was
supported by grants from the Canadian Institute for Health
Research.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.ydbio.2007.03.523.
References
Alvarez-Garcia, I., Miska, E.A., 2005. MicroRNA functions in animal
development and human disease. Development 132, 4653–4662.
Anderson, E.D., Molloy, S.S., Jean, F., Fei, H., Shimamura, S., Thomas, G.,
2002. The ordered and compartment-specific autoproteolytic removal of the
furin intramolecular chaperone is required for enzyme activation. J. Biol.
Chem. 277, 12879–12890.
Ayton, P., Sneddon, S.F., Palmer, D.B., Rosewell, I.R., Owen, M.J., Young, B.,
Presley, R., Subramanian, V., 2001. Truncation of theMll gene in exon 5 by
gene targeting leads to early preimplantation lethality of homozygous
embryos. Genesis 30, 201–212.
Basak, A., Lazure, C., 2003. Synthetic peptides derived from the prosegments of
proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.
Biochem. J. 373, 231–239.
Basak, A., Koch, P., Dupelle, M., Fricker, L.D., Devi, L.A., Chretien, M.,
Seidah, N.G., 2001. Inhibitory specificity and potency of proSAAS-derived
peptides toward proprotein convertase 1. J. Biol. Chem. 276, 32720–32728.
Benjannet, S., Rondeau, N., Day, R., Chrétien, M., Seidah, N.G., 1991. PC1 and
PC2 are proprotein convertases capable of cleaving proopiomelanocortin at
distinct pairs of basic residues. Proc. Natl. Acad. Sci. U. S. A. 88,
3564–3568.
Benjannet, S., Rondeau, N., Paquet, L., Boudreault, A., Lazure, C., Chrétien,
M., Seidah, N.G., 1993. Comparative biosynthesis, covalent post-transla-
tional modifications and efficiency of prosegment cleavage of the
prohormone convertases PC1 and PC2: glycosylation, sulphation and
identification of the intracellular site of prosegment cleavage of PC1 and
PC2. Biochem. J. 294, 735–743.
Benjannet, S., Savaria, D., Chrétien, M., Seidah, N.G., 1995. 7B2 is a specific
intracellular binding protein of the prohormone convertase PC2. J. Neuro-
chem. 64, 2303–2311.
Benjannet, S., Savaria, D., Laslop, A., Munzer, J.S., Chrétien, M.,
Marcinkiewicz, M., Seidah, N.G., 1997. Alpha1-antitrypsin Portland
inhibits processing of precursors mediated by proprotein convertases
primarily within the constitutive secretory pathway. J. Biol. Chem. 272,
26210–26218.Boudreault, A., Gauthier, D., Lazure, C., 1998. Proprotein convertase PC1/3-
related peptides are potent slow tight-binding inhibitors of murine PC1/3 and
Hfurin. J. Biol. Chem. 273, 31574–31580.
Braks, J.A., Martens, G.J., 1994. 7B2 is a neuroendocrine chaperone that
transiently interacts with prohormone convertase PC2 in the secretory
pathway. Cell 78, 263–273.
Casan, E.M., Raga, F., Polan, M.L., 1999. GnRH mRNA and protein expression
in human preimplantation embryos. Mol. Hum. Reprod. 5, 234–239.
Casan, E.M., Raga, F., Bonilla-Musoles, F., Polan, M.L., 2000. Human
oviductal gonadotropin-releasing hormone: possible implications in fertili-
zation, early embryonic development, and implantation. J. Clin. Endocrinol.
Metab. 85, 1377–1381.
Che, F.Y., Lim, J., Pan, H., Biswas, R., Fricker, L.D., 2005. Quantitative
neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol.
Cell. Proteomics 4, 1391–1405.
Chrétien, M., Seidah, N.G., 1981. Chemistry and biosynthesis of pro-
opiomelanocortin. ACTH, MSH's, endorphins and their related peptides.
Mol. Cell. Biochem. 34, 101–127.
Dalton, T., Kover, K., Dey, S.K., Andrews, G.K., 1994. Analysis of the
expression of growth factor, interleukin-1, and lactoferrin genes and the
distribution of inflammatory leukocytes in the preimplantation mouse
oviduct. Biol. Reprod. 51, 597–606.
de Boer, J., Donker, I., de Wit, J., Hoeijmakers, J.H., Weeda, G., 1998.
Disruption of the mouse xeroderma pigmentosum group D DNA repair/
basal transcription gene results in preimplantation lethality. Cancer Res. 58,
89–94.
Dey, A., Norrbom, C., Zhu, X., Stein, J., Zhang, C., Ueda, K., Steiner, D.F.,
2004. Furin and prohormone convertase 1/3 are major convertases in the
processing of mouse pro-growth hormone-releasing hormone. Endocrinol-
ogy 145, 1961–1971.
Doherty, A.S., Temeles, G.L., Schultz, R.M., 1994. Temporal pattern of IGF-I
expression during mouse preimplantation embryogenesis. Mol. Reprod.
Dev. 37, 21–26.
Duhl, D.M., Stevens, M.E., Vrieling, H., Saxon, P.J., Miller, M.W., Epstein,
C.J., Barsh, G.S., 1994. Pleiotropic effects of the mouse lethal yellow (Ay)
mutation explained by deletion of a maternally expressed gene and the
simultaneous production of agouti fusion RNAs. Development 120,
1695–1708.
Fabian, D., Il'kova, G., Rehak, P., Czikkova, S., Baran, V., Koppel, J., 2004.
Inhibitory effect of IGF-I on induced apoptosis in mouse preimplantation
embryos cultured in vitro. Theriogenology 61, 745–755.
Fricker, L.D., McKinzie, A.A., Sun, J., Curran, E., Qian, Y., Yan, L., Patterson,
S.D., Courchesne, P.L., Richards, B., Levin, N., Mzhavia, N., Devi, L.A.,
Douglass, J., 2000. Identification and characterization of proSAAS, a
granin-like neuroendocrine peptide precursor that inhibits prohormone
processing. J. Neurosci. 20, 639–648.
Ftouhi, N., Day, R., Mbikay, M., Chrétien, M., Seidah, N.G., 1994. Gene
organization of the mouse pro-hormone and pro-protein convertase PC1.
DNA Cell Biol. 13, 395–407.
Fugere, M., Limperis, P.C., Beaulieu-Audy, V., Gagnon, F., Lavigne, P.,
Klarskov, K., Leduc, R., Day, R., 2002. Inhibitory potency and specificity of
subtilase-like pro-protein convertase (SPC) prodomains. J. Biol. Chem. 277,
7648–7656.
Holland, P.M., Abramson, R.D., Watson, R., Gelfand, D.H., 1991. Detection of
specific polymerase chain reaction product by utilizing the 5′–3′
exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl.
Acad. Sci. U. S. A. 88, 7276–7280.
Jackson, R.S., Creemers, J.W., Ohagi, S., Raffin-Sanson, M.L., Sanders, L.,
Montague, C.T., Hutton, J.C., O'Rahilly, S., 1997. Obesity and impaired
prohormone processing associated with mutations in the human prohormone
convertase 1 gene. Nat. Genet. 16, 303–306.
Jackson, R.S., Creemers, J.W., Farooqi, I.S., Raffin-Sanson, M.L., Varro, A.,
Dockray, G.J., Holst, J.J., Brubaker, P.L., Corvol, P., Polonsky, K.S.,
Ostrega, D., Becker, K.L., Bertagna, X., Hutton, J.C., White, A., Dattani,
M.T., Hussain, K., Middleton, S.J., Nicole, T.M., Milla, P.J., Lindley, K.J.,
O'Rahilly, S., 2003. Small-intestinal dysfunction accompanies the
complex endocrinopathy of human proprotein convertase 1 deficiency.
J. Clin. Invest. 112, 1550–1560.
597M. Mbikay et al. / Developmental Biology 306 (2007) 584–598Jousan, F.D., Hansen, P.J., 2004. Insulin-like growth factor-I as a survival factor
for the bovine preimplantation embryo exposed to heat shock. Biol. Reprod.
71, 1665–1670.
Jutras, I., Seidah, N.G., Reudelhuber, T.L., Brechler, V., 1997. Two activation
states of the prohormone convertase PC1 in the secretory pathway. J. Biol.
Chem. 272, 15184–15188.
Jutras, I., Seidah, N.G., Reudelhuber, T.L., 2000. A predicted alpha-helix
mediates targeting of the proprotein convertase PC1 to the regulated
secretory pathway. J. Biol. Chem. 275, 40337–40343.
Kawamura, K., Fukuda, J., Kumagai, J., Shimizu, Y., Kodama, H., Nakamura,
A., Tanaka, T., 2005. Gonadotropin-releasing hormone I analog acts as an
anti-apoptotic factor in mouse blastocysts. Endocrinology 146, 4105–4116.
Kurabuchi, S., Tanaka, S., 2002. Immunocytochemical localization of
prohormone convertases PC1 and PC2 in the mouse thyroid gland and
respiratory tract. J. Histochem. Cytochem. 50, 903–909.
Lawitts, J.A., Biggers, J.D., 1993. Culture of preimplantation embryos. Methods
Enzymol. 225, 153–164.
Lee, S.N., Prodhomme, E., Lindberg, I., 2004. Prohormone convertase 1 (PC1)
processing and sorting: effect of PC1 propeptide and proSAAS. J. Endocrinol.
182, 353–364.
Lighten, A.D., Hardy, K., Winston, R.M., Moore, G.E., 1997. Expression of
mRNA for the insulin-like growth factors and their receptors in human
preimplantation embryos. Mol. Reprod. Dev. 47, 134–139.
Lloyd, D.J., Bohan, S., Gekakis, N., 2006. Obesity, hyperphagia and increased
metabolic efficiency in PC1 mutant mice. Hum. Mol. Genet. 15,
1884–1893.
Lyon, M.F., 2003. Transmission ratio distortion in mice. Annu. Rev. Genet. 37,
393–408.
Malide, D., Seidah, N.G., Chrétien, M., Bendayan, M., 1995. Electron
microscopic immunocytochemical evidence for the involvement of the
convertases PC1 and PC2 in the processing of proinsulin in pancreatic beta-
cells. J. Histochem. Cytochem. 43, 11–19.
Marcinkiewicz, M., Day, R., Seidah, N.G., Chrétien, M., 1993. Ontogeny of the
prohormone convertases PC1 and PC2 in the mouse hypophysis and their
colocalization with corticotropin and alpha-melanotropin. Proc. Natl. Acad.
Sci. U. S. A. 90, 4922–4926.
Marcinkiewicz, M., Ramla, D., Seidah, N.G., Chrétien, M., 1994. Develop-
mental expression of the prohormone convertases PC1 and PC2 in mouse
pancreatic islets. Endocrinology 135, 1651–1660.
Martens, G.J., Braks, J.A., Eib, D.W., Zhou, Y., Lindberg, I., 1994. The
neuroendocrine polypeptide 7B2 is an endogenous inhibitor of prohormone
convertase PC2. Proc. Natl. Acad. Sci. U. S. A. 91, 5784–5787.
Marzban, L., Trigo-Gonzales, G., Zhu, X.R., Rhodes, C.J., Halban, P.A.,
Steiner, D.F., Verchere, C.B., 2004. Role of beta-cell prohormone convertase
(PC) 1/3 in processing of pro-islet antyloid polypeptide. Diabetes 53,
141–148.
Mbikay, M., Tadros, H., Ishida, N., Lerner, C.P., De Lamirande, E., Chen, A.,
El-Alfy, M., Clermont, Y., Seidah, N.G., Chrétien, M., Gagnon, C.,
Simpson, E.M., 1997. Impaired fertility in mice deficient for the testicular
germ-cell protease PC4. Proc. Natl. Acad. Sci. U. S. A. 94, 6842–6846.
Mbikay, M., Seidah, N.G., Chretien, M., 2001. Neuroendocrine secretory
protein 7B2: structure, expression and functions. Biochem. J. 357, 329–342.
Michaud, E.J., Bultman, S.J., Stubbs, L.J., Woychik, R.P., 1993. The embryonic
lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the
disruption of a novel RNA-binding protein. Genes Dev. 7, 1203–1213.
Muller, L., Zhu, X., Lindberg, I., 1997. Mechanism of the facilitation of PC2
maturation by 7B2: involvement in ProPC2 transport and activation but not
folding. J. Cell Biol. 139, 625–638.
Muller, L., Cameron, A., Fortenberry, Y., Apletalina, E.V., Lindberg, I., 2000.
Processing and sorting of the prohormone convertase 2 propeptide. J. Biol.
Chem. 275, 39213–39222.
O'Neill, C., 1998. Autocrine mediators are required to act on the embryo by the
2-cell stage to promote normal development and survival of mouse
preimplantation embryos in vitro. Biol. Reprod. 58, 1303–1309.
Paquet, L., Bergeron, F., Boudreault, A., Seidah, N.G., Chretien, M., Mbikay,
M., Lazure, C., 1994. The neuroendocrine precursor 7B2 is a sulfated
protein proteolytically processed by a ubiquitous furin-like convertase.
J. Biol. Chem. 269, 19279–19285.Paria, B.C., Dey, S.K., 1990. Preimplantation embryo development in vitro:
cooperative interactions among embryos and role of growth factors. Proc.
Natl. Acad. Sci. U. S. A. 87, 4756–4760.
Peinado, J.R., Laurent, V., Lee, S.N., Peng, B.W., Pintar, J.E., Steiner, D.F.,
Lindberg, I., 2005. Strain-dependent influences on the hypothalamo–
pituitary–adrenal axis profoundly affect the 7B2 and PC2 null phenotypes.
Endocrinology.
Qian, Y., Devi, L.A., Mzhavia, N., Munzer, S., Seidah, N.G., Fricker, L.D.,
2000. The C-terminal region of proSAAS is a potent inhibitor of
prohormone convertase 1. J. Biol. Chem. 275, 23596–23601.
Raga, F., Casan, E.M., Kruessel, J., Wen, Y., Bonilla-Musoles, F., Polan, M.L.,
1999. The role of gonadotropin-releasing hormone in murine preimplanta-
tion embryonic development. Endocrinology 140, 3705–3712.
Reese, M.G., Eeckman, F.H., Kulp, D., Haussler, D., 1997. Improved splice site
detection in Genie. J. Comput. Biol. 4, 311–323.
Rehemtulla, A., Dorner, A.J., Kaufman, R.J., 1992. Regulation of PACE
propeptide-processing activity: requirement for a post-endoplasmic reticu-
lum compartment and autoproteolytic activation. Proc. Natl. Acad. Sci.
U. S. A. 89, 8235–8239.
Rinchik, E.M., Tonjes, R.R., Paul, D., Potter, M.D., 1993. Molecular analysis of
radiation-induced albino (c)-locus mutations that cause death at preimplan-
tation stages of development. Genetics 135, 1107–1116.
Schäfer, M.K., Day, R., Cullinan, W.E., Chrétien, M., Seidah, N.G., Watson,
S.J., 1993. Gene expression of prohormone and proprotein convertases in
the rat CNS: a comparative in situ hybridization analysis. J. Neurosci. 13,
1258–1279.
Seidah, N.G., Chretien, M., 1999. Proprotein and prohormone convertases: a
family of subtilases generating diverse bioactive polypeptides. Brain Res.
848, 45–62.
Seidah, N.G., Gaspar, L., Mion, P., Marcinkiewicz, M., Mbikay, M., Chrétien,
M., 1990. cDNA sequence of two distinct pituitary proteins homologous to
Kex2 and furin gene products: tissue-specific mRNAs encoding candidates
for pro-hormone processing proteinases. DNA Cell Biol. 9, 789.
Seidah, N.G., Marcinkiewicz, M., Benjannet, S., Gaspar, L., Beaubien, G.,
Mattei, M.G., Lazure, C., Mbikay, M., Chrétien, M., 1991. Cloning and
primary sequence of a mouse candidate prohormone convertase PC1
homologous to PC2, Furin, and Kex2: distinct chromosomal localization and
messenger RNA distribution in brain and pituitary compared to PC2. Mol.
Endocrinol. 5, 111–122.
Seidah, N.G., Chrétien, M., Day, R., 1994. The family of subtilisin/kexin like
pro-protein and pro-hormone convertases: divergent or shared functions.
Biochimie 76, 197–209.
Smeekens, S.P., Avruch, A.S., LaMendola, J., Chan, S.J., Steiner, D.F., 1991.
Identification of a cDNA encoding a second putative prohormone
convertase related to PC2 in AtT20 cells and islets of Langerhans. Proc.
Natl. Acad. Sci. U. S. A. 88, 340–344.
Smeekens, S.P., Montag, A.G., Thomas, G., Albiges-Rizo, C., Carroll, R.,
Benig, M., Phillips, L.A., Martin, S., Ohagi, S., Gardner, P., Swift, H.H.,
Steiner, D.F., 1992. Proinsulin processing by the subtilisin-related proprotein
convertases furin, PC2, and PC3. Proc. Natl. Acad. Sci. U. S. A. 89,
8822–8826.
Steiner, D.F., 1998. The proprotein convertases. Curr. Opin. Chem. Biol. 2,
31–39.
St. Germain, C., Croissandeau, G., Mayne, J., Baltz, J.M., Chretien, M., Mbikay,
M., 2005. Expression and transient nuclear translocation of proprotein
convertase 1 (PC1) during mouse preimplantation embryonic development.
Mol. Reprod. Dev. 72, 483–493.
Takumi, I., Steiner, D.F., Sanno, N., Teramoto, A., Osamura, R.Y., 1998.
Localization of prohormone convertases 1/3 and 2 in the human pituitary
gland and pituitary adenomas: analysis by immunohistochemistry, immu-
noelectron microscopy, and laser scanning microscopy. Mod. Pathol. 11,
232–238.
Tsuji, A., Ikoma, T., Hashimoto, E., Matsuda, Y., 2002. Development of
selectivity of alpha1-antitrypsin variant by mutagenesis in its reactive site
loop against proprotein convertase. A crucial role of the P4 arginine in
PACE4 inhibition. Protein Eng. 15, 123–130.
Ueda, K., Lipkind, G.M., Zhou, A., Zhu, X., Kuznetsov, A., Philipson, L.,
Gardner, P., Zhang, C., Steiner, D.F., 2003. Mutational analysis of predicted
598 M. Mbikay et al. / Developmental Biology 306 (2007) 584–598interactions between the catalytic and P domains of prohormone convertase
3 (PC3/PC1). Proc. Natl. Acad. Sci. U. S. A. 100, 5622–5627.
Wang, H., Dey, S.K., 2006. Roadmap to embryo implantation: clues from mouse
models. Nat. Rev. Genet. 7, 185–199.
Wu, G., Hao, L., Han, Z., Gao, S., Latham, K.E., de Villena, F.P., Sapienza, C.,
2005. Maternal transmission ratio distortion at the mouse Om locus results
from meiotic drive at the second meiotic division. Genetics 170, 327–334.
Yonemasu, R., Minami, M., Nakatsu, Y., Takeuchi, M., Kuraoka, I., Matsuda,
Y., Higashi, Y., Kondoh, H., Tanaka, K., 2005. Disruption of mouse XAB2
gene involved in pre-mRNA splicing, transcription and transcription-
coupled DNA repair results in preimplantation lethality. DNA Repair 4,
479–491.
Yu, P., Ma, D., Xu, M., 2005. Nested genes in the human genome. Genomics 86,
414–422.
Zheng, M., Streck, R.D., Scott, R.E., Seidah, N.G., Pintar, J.E., 1994. The
developmental expression in rat of proteases furin, PC1, PC2, and
carboxypeptidase E: implications for early maturation of proteolytic
processing capacity. J. Neurosci. 14, 4656–4673.Zhou, A., Bloomquist, B.T., Mains, R.E., 1993. The prohormone convertases
PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal
order during proopiomelanocortin biosynthetic processing. J. Biol. Chem.
268, 1763–1769.
Zhu, Q., Lindenbaum, M., Levavasseur, F., Jacomy, H., Julien, J.P., 1998.
Disruption of the NF-H gene increases axonal microtubule content and
velocity of neurofilament transport: relief of axonopathy resulting from the
toxin beta,beta′-iminodipropionitrile. J. Cell Biol. 143, 183–193.
Zhu, X.R., Orci, L., Carroll, R., Norrbom, C., Ravazzola, M., Steiner, D.F.,
2002a. Severe block in processing of proinsulin to insulin accompanied by
elevation of des-64,65 proinsulin intermediates in islets of mice lacking
prohormone convertase-1/3. Proc. Natl. Acad. Sci. U. S. A. 99,
10299–10304.
Zhu, X.R., Zhou, A., Dey, A., Norrbom, C., Carroll, R., Zhang, C.L., Laurent,
V., Lindberg, I., Ugleholdt, R., Holst, J.J., Steiner, D.F., 2002b. Disruption of
PC1/3 expression in mice causes dwarfism and multiple neuroendocrine
peptide processing defects. Proc. Natl. Acad. Sci. U. S. A. 99,
10293–10298.
